These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23933369)

  • 1. Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.
    Zariri A; van Dijken H; Hamstra HJ; van der Flier M; Vidarsson G; van Putten JP; Boog CJ; van den Dobbelsteen G; van der Ley P
    Vaccine; 2013 Nov; 31(47):5585-93. PubMed ID: 23933369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.
    de Jonge MI; Hamstra HJ; Jiskoot W; Roholl P; Williams NA; Dankert J; van Alphen L; van der Ley P
    Vaccine; 2004 Sep; 22(29-30):4021-8. PubMed ID: 15364452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.
    Lee HS; Boulton IC; Reddin K; Wong H; Halliwell D; Mandelboim O; Gorringe AR; Gray-Owen SD
    Infect Immun; 2007 Sep; 75(9):4449-55. PubMed ID: 17620353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
    Jones C; Sadarangani M; Lewis S; Payne I; Saleem M; Derrick JP; Pollard AJ
    PLoS One; 2016; 11(4):e0154153. PubMed ID: 27111850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
    Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
    Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens.
    Williams JN; Weynants V; Poolman JT; Heckels JE; Christodoulides M
    Vaccine; 2014 Mar; 32(11):1280-6. PubMed ID: 24486354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.
    de Jonge MI; Hamstra HJ; van Alphen L; Dankert J; van der Ley P
    Mol Microbiol; 2003 Nov; 50(3):1005-15. PubMed ID: 14617157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
    Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
    Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis.
    de Jonge MI; Vidarsson G; van Dijken HH; Hoogerhout P; van Alphen L; Dankert J; van der Ley P
    Infect Immun; 2003 May; 71(5):2331-40. PubMed ID: 12704102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells.
    Youssef AR; van der Flier M; Estevão S; Hartwig NG; van der Ley P; Virji M
    Infect Immun; 2009 Nov; 77(11):5170-80. PubMed ID: 19720754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.
    Tunheim G; Arnemo M; Naess LM; Norheim G; Garcia L; Cardoso D; Mandiarote A; Gonzalez D; Sinnadurai K; Fjeldheim ÅK; Bolstad K; Rosenqvist E
    APMIS; 2016 Nov; 124(11):996-1003. PubMed ID: 27651089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
    Hou VC; Koeberling O; Welsch JA; Granoff DM
    J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.
    Rosenqvist E; Høiby EA; Bjune G; Bryn K; Closs O; Feiring B; Klem A; Nøkleby H; Frølm LO
    NIPH Ann; 1991 Dec; 14(2):169-79; discussion 180-1. PubMed ID: 1687481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
    Sadarangani M; Hoe JC; Callaghan MJ; Jones C; Chan H; Makepeace K; Daniels-Treffandier H; Deadman ME; Bayliss C; Feavers I; van der Ley P; Pollard AJ
    PLoS One; 2012; 7(12):e51045. PubMed ID: 23251421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.